CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

1 hour ago
share
Share Via
CARE Ratings Ltd has experienced a subtle but noteworthy shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the weekly charts. Despite this positive directional change, the stock’s technical indicators present a nuanced picture, with mixed signals across key measures such as MACD, RSI, moving averages, and Bollinger Bands. This article analyses these developments in detail, placing CARE Ratings’ price action in the context of broader market performance and technical benchmarks.
CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

CARE Ratings Ltd (stock code 734522), operating within the Capital Markets sector, currently trades at ₹1,606.70, marginally up 0.26% from the previous close of ₹1,602.60. The stock’s intraday range on 26 Feb 2026 spanned ₹1,588.85 to ₹1,626.30, reflecting moderate volatility. Over the past 52 weeks, the share price has oscillated between ₹1,057.65 and ₹1,964.80, indicating a substantial trading band of nearly 86% from low to high.

The recent technical trend shift from mildly bearish to mildly bullish on the weekly timeframe suggests improving price momentum, potentially signalling a nascent recovery phase. However, the daily moving averages remain mildly bearish, indicating that short-term momentum has yet to fully align with the weekly trend improvement.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator offers a mixed outlook. On the weekly chart, MACD is bullish, supporting the recent positive momentum shift. This bullish MACD reading implies that the short-term moving average is above the longer-term average, signalling upward momentum. Conversely, the monthly MACD remains mildly bearish, suggesting that the longer-term trend has not yet confirmed a sustained uptrend.

The Know Sure Thing (KST) indicator echoes this divergence, showing bullish momentum on the weekly scale but mildly bearish readings monthly. This disparity between short- and long-term momentum indicators highlights a transitional phase for CARE Ratings, where weekly strength may be an early sign of a broader trend reversal.

RSI and Overbought/Oversold Conditions

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, indicating that the stock is neither overbought nor oversold. This neutral RSI suggests that CARE Ratings is trading within a balanced momentum range, without extreme buying or selling pressure. Such a condition often precedes a decisive directional move, making the stock’s near-term trajectory dependent on forthcoming market catalysts.

Bollinger Bands and Volatility

Bollinger Bands on both weekly and monthly timeframes are bullish, signalling that price volatility is expanding in a positive direction. The stock price is likely trading near or above the upper band on these timeframes, which often indicates strong buying interest and potential continuation of the upward move. This technical setup supports the weekly bullish MACD and KST signals, reinforcing the case for improving momentum.

Moving Averages and Volume Trends

Despite the encouraging weekly momentum, daily moving averages remain mildly bearish, reflecting some short-term resistance or consolidation. This divergence between daily and weekly averages suggests that while the medium-term outlook is improving, investors should be cautious of near-term pullbacks or sideways price action.

On the volume front, the On-Balance Volume (OBV) indicator presents a split view: mildly bearish on the weekly chart but bullish on the monthly chart. This indicates that while recent weekly volume trends have been weak, the longer-term accumulation remains positive, supporting the stock’s potential for sustained gains.

Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.

  • - Investment Committee approved
  • - 50+ candidates screened
  • - Strong post-announcement performance

See Why It Was Chosen →

Dow Theory and Broader Market Context

According to Dow Theory, the weekly trend for CARE Ratings is mildly bullish, while the monthly trend shows no clear directional bias. This aligns with the mixed signals from other technical indicators and suggests that the stock is in a phase of tentative recovery rather than a confirmed uptrend.

Comparing CARE Ratings’ returns with the Sensex provides further perspective. Over the past week, CARE Ratings declined by 2.14%, slightly underperforming the Sensex’s 1.74% drop. However, over longer horizons, the stock has significantly outperformed the benchmark. Year-to-date, CARE Ratings is up 0.37% while Sensex is down 3.46%. Over one year, the stock surged 38.03% compared to Sensex’s 10.29%. The three- and five-year returns are even more impressive, with CARE Ratings delivering 149.22% and 238.07% respectively, vastly exceeding Sensex’s 38.36% and 61.20%. This strong historical outperformance underscores the stock’s resilience and growth potential despite recent short-term volatility.

Mojo Score and Analyst Ratings

CARE Ratings currently holds a Mojo Score of 48.0, categorised as a Sell grade, downgraded from Hold on 23 Feb 2026. This downgrade reflects caution from MarketsMOJO’s quantitative assessment, which factors in fundamentals, technicals, and market sentiment. The Market Cap Grade stands at 3, indicating a mid-tier capitalisation relative to peers in the Capital Markets sector.

The downgrade to Sell suggests that despite the improving weekly technical momentum, the overall risk-reward profile remains unfavourable at present. Investors should weigh this against the stock’s longer-term outperformance and the mixed technical signals before making allocation decisions.

CARE Ratings Ltd or something better? Our SwitchER feature analyzes this small-cap Capital Markets stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Investor Takeaway and Outlook

CARE Ratings Ltd is currently navigating a complex technical landscape. The weekly shift to a mildly bullish trend, supported by positive MACD and Bollinger Bands readings, indicates improving momentum that could attract renewed buying interest. However, the absence of clear RSI signals and the mildly bearish daily moving averages counsel prudence, as short-term volatility and consolidation remain likely.

Long-term investors may find comfort in the stock’s robust multi-year returns, which have consistently outpaced the Sensex by wide margins. Yet, the recent downgrade to a Sell grade by MarketsMOJO highlights underlying concerns, possibly related to valuation or sector-specific risks.

In summary, CARE Ratings presents a mixed technical and fundamental picture. Traders might consider the weekly bullish signals as an opportunity for tactical entries, while longer-term investors should monitor for confirmation of sustained trend improvement before increasing exposure.

Summary of Key Technical Indicators:

  • Weekly MACD: Bullish
  • Monthly MACD: Mildly Bearish
  • Weekly RSI: Neutral (No Signal)
  • Monthly RSI: Neutral (No Signal)
  • Weekly Bollinger Bands: Bullish
  • Monthly Bollinger Bands: Bullish
  • Daily Moving Averages: Mildly Bearish
  • Weekly KST: Bullish
  • Monthly KST: Mildly Bearish
  • Weekly Dow Theory: Mildly Bullish
  • Monthly Dow Theory: No Trend
  • Weekly OBV: Mildly Bearish
  • Monthly OBV: Bullish

Price and Return Highlights:

  • Current Price: ₹1,606.70
  • 52-Week High: ₹1,964.80
  • 52-Week Low: ₹1,057.65
  • 1 Week Return: -2.14% (Sensex: -1.74%)
  • 1 Month Return: +2.34% (Sensex: +0.91%)
  • Year-to-Date Return: +0.37% (Sensex: -3.46%)
  • 1 Year Return: +38.03% (Sensex: +10.29%)
  • 3 Year Return: +149.22% (Sensex: +38.36%)
  • 5 Year Return: +238.07% (Sensex: +61.20%)
  • 10 Year Return: +78.00% (Sensex: +258.10%)

Investors should continue to monitor CARE Ratings’ technical indicators closely, particularly the alignment of daily and weekly moving averages and the evolution of MACD and KST on monthly charts, to better gauge the sustainability of the current momentum shift.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News